 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.  
         Italics indicate opposite chamber/conference committee amendments.             *hb0970*      
HOUSE BILL 970  
J5, J4    (5lr2851 ) 
ENROLLED BILL  
— Health and Government Operations/Finance  — 
Introduced by Delegates Woods, Alston, Bagnall, Bhandari, Chisholm, Davis, 
Fisher, Ghrist, Guzzone, Harris, Harrison, Kaufman, Kerr, J.  Long, Lopez, 
Martinez, McCaskill, M.  Morgan, Patterson, Roberts, Rosenberg, Schmidt, 
Simmons, Szeliga, Taveras, Taylor, Terrasa, and W ilkins  Wilkins, Cullison, 
Hill, Hutchinson, S.  Johnson, Kaiser, Kipke, Pena –Melnyk, Reilly, Ross, 
White  Holland, and Woorman  
 
Read and Examined by Proofreaders:  
 
_______________________________________________  
Proofreader.  
_______________________________ ________________  
Proofreader.  
 
Sealed with the Great Seal and presented to the Governor, for his approval this  
  
_______ day of _______________ at ________________________ o’clock, ________M.  
  
______________________________________________  
Speaker .  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Health Insurance – Insulin – Prohibition on Step Therapy or Fail –First 2 
Protocols  3 
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 4 
maintenance organizations from imposing a ste p therapy or fail –first protocol on 5 
insulin or an insulin analog  or certain other similar medications  used to treat an 6 
insured’s or enrollee’s diabetes; and generally relating to use of step therapy and 7 
fail–first protocols.  8 
 
BY repealing and reenacting,  without amendments,  9 
2 HOUSE BILL 970   
 
  Article – Insurance  1 
Section 15 –142(a)(1) and (4) and (b)  2 
 Annotated Code of Maryland  3 
 (2017 Replacement Volume and 2024 Supplement)  4 
 
BY repealing and reenacting, with amendments,  5 
 Article – Insurance  6 
Section 15 –142(e)  7 
 Annotated Code of Maryland  8 
 (2017 Replacement Volume and 2024 Supplement)  9 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 10 
That the Laws of Maryland read as follows:  11 
 
Article – Insurance  12 
 
15–142. 13 
 
 (a) (1) In this section the following words have the meanings indicated.  14 
 
  (4) (i) “Step therapy or fail –first protocol” means a protocol established 15 
by an insurer, a nonprofit health service plan, or a health maintenance organization that 16 
requires a prescription drug or sequence of prescription drugs to be  used by an insured or 17 
an enrollee before a prescription drug ordered by a prescriber for the insured or the enrollee 18 
is covered.  19 
 
   (ii) “Step therapy or fail –first protocol” includes a protocol that 20 
meets the definition under subparagraph (i) of this pa ragraph regardless of the name, label, 21 
or terminology used by the insurer, nonprofit health service plan, or health maintenance 22 
organization to identify the protocol.  23 
 
 (b) (1) This section applies to:  24 
 
   (i) insurers and nonprofit health service plans th at provide hospital, 25 
medical, or surgical benefits to individuals or groups on an expense –incurred basis under 26 
health insurance policies or contracts that are issued or delivered in the State; and  27 
 
   (ii) health maintenance organizations that provide hosp ital, 28 
medical, or surgical benefits to individuals or groups under contracts that are issued or 29 
delivered in the State.  30 
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 31 
organization that provides coverage for prescription drugs t hrough a pharmacy benefits 32 
manager is subject to the requirements of this section.  33 
 
 HOUSE BILL 970  3 
 
  (e) An entity subject to this section may not impose a step therapy or fail –first 1 
protocol on an insured or an enrollee for a prescription drug approved by the U.S. Food a nd 2 
Drug Administration if:  3 
 
  (1) (I) the prescription drug is used to treat the insured’s or enrollee’s 4 
stage four advanced metastatic cancer; and  5 
 
  [(2)] (II) use of the prescription drug is:  6 
 
   [(i)] 1. consistent with the U.S. Food and Drug  7 
Administration –approved indication or the National Comprehensive Cancer Network 8 
Drugs & Biologics Compendium indication for the treatment of stage four advanced 9 
metastatic cancer; and  10 
 
   [(ii)] 2. supported by peer –reviewed medical literature ; OR 11 
 
  (2) THE PRESCRIPTION DRUG  IS:  12 
 
   (I) INSULIN  OR AN INSULIN ANALOG  USED TO TREAT THE 13 
INSURED ’S OR ENROLLEE ’S TYPE 1, TYPE 2, OR GESTATIONAL DIABE TES; AND  14 
 
   (II) 1. INSULIN ; OR 15 
 
    2. AN INSULIN ANALOG OR  OTHER PRESCRIPTION D RUG  16 
THAT PERFORMS A SIMI LAR FUNCTION TO INSULIN , REGARDLESS OF THE  17 
ACTIVATION PERIOD , WHETHER THE SOLUTION  IS MIXED BEFORE OR A FTER  18 
DISPENSING , OR WHETHER THE DRUG IS ADMINISTERED BY I NJECTION OR  19 
INHALATION . 20 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 21 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 22 
after January 1, 2026.  23 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 24 
January 1, 2026.  25 